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“Beyond aid” investments in private healthcare in
developing countries
The UK government’s investment in commercial hospital chains merits greater scrutiny
Benjamin M Hunter doctoral student, Susan F Murray reader in international healthcare
International Development Institute, King’s College London, London WC2R 2LS, UK
An inquiry by the House of Commons International
Development Committee published in February 2015 proposed
a transition to “beyond aid” policies.1 The rationale for this
transition was clearly stated: traditional forms of aid address
the symptoms of poverty “at a substantial short-term cost.” In
contrast, beyond aid policies aim to tackle underlying causes
of poverty and “would be good for the UK in the short run as
well as in the long run.”
Beyond aid policies emphasise the use of loans and equity
investments to support the growth of a range of private sector
companies. In December 2014, for example, the secretary of
state for international development, Justine Greening, described
a transition towards “returnable capital investments” in Indian
health and education sectors.2Amonth later the Department for
International Development’s investment arm, CDC Group,
announced a $48m (£32m; €42m) investment in Narayana
Health, an Indian corporate hospital chain.3
The UK government’s interest in capital investments in the
private hospital industry is part of a troubling wider (and poorly
documented) international trend. We used a combination of
online project databases and annual reports to conduct a
preliminary mapping of investment commitments to private
hospitals and clinics by the CDC Group and other similar
development financing institutions.4-10 We identified
commitments that totalled at least $2.3bn, of which $1.9bn was
committed within the past eight years. The World Bank’s
International Finance Corporation is the largest investor in such
private hospitals and clinics, but our data suggest that other
development financing institutions (in particular those of France,
Germany, the UK, and Sweden) have also become increasingly
supportive in this sector.
The biggest recipients of investment have been large commercial
hospital chains in the emerging economy countries. Our data
suggest that nearly two thirds of commitments went to
companies in India ($470m), Turkey ($345m), Brazil ($232m),
China ($176m), Russia ($123m), and South Africa ($100m).
Of the nine hospital corporates to receive commitments of at
least $50m since 2007, five are international chains (Saudi
German Hospitals, Apollo Hospitals, Fortis Healthcare, IHH
Healthcare Berhad, and Life Healthcare) and four are national
chains (MaxHealthcare, AcibademHealthcareGroup,Medicina,
and Rede D’Or).
Direct investments in private hospitals by the UK government’s
CDC Group have grown since a strategy change in 2012. Its
two direct investments between 2000 and 2012 ($6.1m in Prime
Cure Clinics, South Africa, and $5m in Apollo Hospital Dhaka,
Bangladesh) have been dwarfed by investments of some $65.5m
since (in Rainbow Hospitals and Narayana Health, both India),
which are expected to enable these hospital chains to expand to
new cities.
Costs and distortions
Investments by development financing institutions tend to be
made using criteria of job creation and returns on investment.
It would seem that their effects on health systems, health equity,
and poverty have largely avoided scrutiny until now. But easy
assumptions about the contribution of the commercial sector to
improving health coverage for poor people need to be
challenged. High throughput models of profitable healthcare
treatments are being rapidly rolled out in the absence of robust
evidence of their affordability or appropriateness. A recent
rigorous review found “very limited evidence” that such models
offer good prospects for extending services to the poor in the
future.11
Impoverishment caused by healthcare costs is also a documented
concern in many countries.12 Although catastrophic costs can
be incurred in public sector hospitals that have user fee systems,
the problem is far greater in the profit generating sector. In India
alone an estimated 2.5 million households are pushed below
the poverty line each year by the costs of inpatient care.13 We
also know from research supported by the Department for
International Development that many more users of private
healthcare are impoverished each year in India than users of the
public sector (48% compared with 15% incur catastrophically
high out of pocket health spending).14 15
This situation is compounded by the distortions in the provision
of care that are known to be encouraged by commercial interests.
Interestingly, it is the World Bank that has become the latest
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voice to draw attention to a worldwide epidemic of medical
overuse—the prescribing of unnecessary medical tests,
procedures, hospital admissions, and operations—citing the role
of “aggressive marketing of services by hospitals,
pharmaceutical firms and the medical device industry” and
“incentives inherent in the way providers are paid for their
services.”16 The bank highlights the marginal benefits of many
procedures and notes that they can lead to unnecessary suffering,
particularly among frail and elderly people.
This scenario arouses concerns that a transition to beyond aid
in the health sector as currently envisaged may undermine
attempts to achieve equitable universal health coverage. Greater
scrutiny is required of beyond aid investments in commercial
hospital chains and other related areas in order to better
determine their effect on poor people’s access to healthcare, on
catastrophic out of pocket health expenditure, and on
opportunities for developing countries to create unified health
systems with an appropriate focus on prevention and on primary
healthcare.
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